SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 144 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2 | -100.0% | 3,200 | -17.9% | 0.00% | – |
Q3 2022 | $6,000 | – | 3,898 | +34.4% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 2,900 | -63.8% | 0.00% | – |
Q1 2022 | $1,000 | -92.9% | 8,000 | +536.9% | 0.00% | -100.0% |
Q4 2018 | $14,000 | -33.3% | 1,256 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $21,000 | +23.5% | 1,256 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $17,000 | -26.1% | 1,256 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $23,000 | -62.9% | 1,256 | -90.1% | 0.00% | -33.3% |
Q4 2017 | $62,000 | -47.9% | 12,700 | -47.7% | 0.00% | -25.0% |
Q3 2017 | $119,000 | +52.6% | 24,300 | -19.0% | 0.00% | +33.3% |
Q2 2017 | $78,000 | +457.1% | 30,000 | -21.1% | 0.00% | – |
Q1 2017 | $14,000 | -82.9% | 38,000 | -35.6% | 0.00% | -100.0% |
Q4 2016 | $82,000 | +2.5% | 58,993 | -64.1% | 0.00% | 0.0% |
Q3 2016 | $80,000 | -73.8% | 164,193 | +32.5% | 0.00% | -80.0% |
Q2 2016 | $305,000 | +43.2% | 123,923 | -38.6% | 0.02% | +7.1% |
Q1 2016 | $213,000 | -68.5% | 201,816 | +11.6% | 0.01% | -63.2% |
Q4 2015 | $677,000 | – | 180,916 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
Leisure Capital Management | 43,008 | $131,000 | 0.12% |
Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |